Results 231 to 240 of about 1,568,965 (311)
The disclosure of potential conflicts of interest among editors and members of editorial boards in leading ethics journals. [PDF]
Faggion CM.
europepmc +1 more source
Aptamers are used both therapeutically and as targeting agents in cancer treatment. We developed an aptamer‐targeted PLGA–TRAIL nanosystem that exhibited superior therapeutic efficacy in NOD/SCID breast cancer models. This nanosystem represents a novel biotechnological drug candidate for suppressing resistance development in breast cancer.
Gulen Melike Demirbolat +8 more
wiley +1 more source
The PI3Kδ inhibitor roginolisib (IOA‐244) preserves T‐cell function and activity
Identification of novel PI3K inhibitors with limited immune‐related adverse effects is highly sought after. We found that roginolisib and idelalisib inhibit chronic lymphocytic leukemia (CLL) cells and Treg suppressive functions to similar extents, but roginolisib affects cytotoxic T‐cell function and promotion of pro‐inflammatory T helper subsets to a
Elise Solli +7 more
wiley +1 more source
Cultural Dimensions of Workplace Violence in Healthcare: A Narrative Review. [PDF]
Morales Palomares S +2 more
europepmc +1 more source
Targeting p38α in cancer: challenges, opportunities, and emerging strategies
p38α normally regulates cellular stress responses and homeostasis and suppresses malignant transformation. In cancer, however, p38α is co‐opted to drive context‐dependent proliferation and dissemination. p38α also supports key functions in cells of the tumor microenvironment, including fibroblasts, myeloid cells, and T lymphocytes.
Angel R. Nebreda
wiley +1 more source
Always available? A systematic review on extended work-related availability, health outcomes and work-family conflict. [PDF]
Renk S, Sutter C.
europepmc +1 more source
When Must a Priest Report Under a Child Abuse Reporting Statute? - Resolution to the Priests\u27 Conflicting Duties [PDF]
Ivers, William N.
core +1 more source
Volume‒outcome relationships in bariatric surgery: a rapid review. [PDF]
Campione A +3 more
europepmc +1 more source

